Price
No data yet.
Social Signal Score
Analyst Ratings
12 analystsRevenue
$152.00M+340.23%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Erwin HaitzmannPeter Hoetzinger
- Sector
- Consumer Cyclical
- Industry
- Gambling, Resorts & Casinos
- Employees
- 3,334
- Beta
- 1.67
- Country
- US
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- 0.43
Financials
Revenue
$152.00M+340.2%Net Income
$-10.91M-678.2%EBITDA
$30.27M+407.2%Free Cash Flow
$5.43M-0.7%EPS (diluted)
$-0.39-587.5%Shares Outstanding (diluted)
28.20M+14.3%Operating Expenses
$36.83MCash & Debt
$60.18MReturn of Capital
$477.0KRevenue by Segment (annual)
$553.14MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $572.98M | $-61.42M | $-2.04 |
| 2024 | $575.92M | $-128.17M | $-4.19 |
| 2023 | $550.21M | $-28.20M | $-0.93 |
| 2022 | $430.53M | $7.98M | $0.46 |
| 2021 | $388.51M | $20.62M | $0.70 |
| 2020 | $304.27M | $-48.00M | $-1.63 |
| 2019 | $218.23M | $-19.16M | $-0.55 |
| 2018 | $168.94M | $3.39M | $0.12 |
| 2017 | $154.07M | $6.26M | $0.25 |
| 2016 | $139.23M | $9.21M | $0.38 |
| 2015 | $134.43M | $11.91M | $0.49 |
| 2014 | $120.05M | $1.23M | $0.05 |
| 2013 | $104.59M | $6.18M | $0.26 |
| 2012 | $71.83M | $4.09M | $0.17 |
Valuation
CNTYhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100-9.09%Social Signal Score
Mentions (3)
- Newsglobenewswire.com·4d ago·Neutral
Century Therapeutics' CNTY-813 Demonstrates Continued Advancement Toward the Clinic Via Nonclinical Data Presented at EASD 2026 Data demonstrated scalable production, in vivo function and immune evasion, and updated progress toward clinical dosing of CNTY-813, Century's iPSC-derived islet replacement therapy for type 1 diabetes
View source ↗ - Newsprnewswire.com·8d ago·Neutral
…l Century Mile and Century Downs Racetracks in Alberta, Canada COLORADO SPRINGS, Colo., Sept. 28, 2026 /PRNewswire/ -- Century Casinos, Inc. (Nasdaq Capital Market®: CNTY) ("Century Casinos" or the "Company") announced today that it has entered into a definitive agreement to sell the racing and gaming operations of Century Mile Racetrack and Casino in Edmonton, Alberta ("Century Mile") and Century Downs Racetrack and Casino in Calgary, Alberta ("Century Downs") to Highfield Investment Group ("Hi…
View source ↗ - Newsglobenewswire.com·55d ago·Positive
Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates Completed pre-IND meeting with the FDA for CNTY-813, an iPSC-derived islet replacement therapy with functional cure potential in type 1 diabetes (T1D); IND submission on track for 4Q 2026 CNTY-813 preclinical data from oral presentation at ADA 2026 showed durable glucose control in vivo, immune evasion, and manufacturing success at clinical scale, advancing its potential as a functional cure for T1D Upcoming
View source ↗
Earnings
Fri, Nov 6(in 4 weeks)
Consensus estimate $-0.21 per share
Typical surprise -19.6% (median, so one quarter with a near-zero estimate can't distort it)
- Fri, Aug 7$-0.39 vs $-0.33miss
- Fri, May 8$-0.58 vs $-0.64beat
- Fri, Mar 13$-0.61 vs $-0.46miss
- Mon, Nov 10$-0.35 vs $-0.28miss
- Thu, Aug 7$-0.40 vs $-0.37miss
- Mon, May 12$-0.67 vs $-0.56miss
Estimates and results for CNTY via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by CNTY officers and directors.
- Bought
- $676k
- Sold
- $1.4m
14 trades
5 trades
- Hoetzinger Peterbought
- Hoetzinger Peterbought
- Hoetzinger Peterbought
- Strohriegel Nikolausbought
- Strohriegel Nikolausbought
- Hoetzinger Peterbought
- Haitzmann Erwin Et Albought
- Haitzmann Erwin Et Albought
81 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Susie Leehouse · NV03 · disclosed Apr 11, 2025 (28d later)Sell$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.